Filing Details

Accession Number:
0000849146-24-000019
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-06 20:15:40
Reporting Period:
2024-01-10
Accepted Time:
2024-02-06 20:15:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
849146 Lifevantage Corp LFVN Pharmaceutical Preparations (2834) 900224471
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1436020 Paul Garry Mauro 3300 Triumph Blvd, Suite 700
Lehi UT 84043
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-10 30,893 $0.00 76,905 No 4 G Direct
Common Stock Acquisiton 2024-02-02 162 $5.66 77,067 No 4 P Direct
Common Stock Acquisiton 2024-01-10 5,893 $0.00 6,438 No 4 G Indirect By Garry Paul Mauro SEP IRA
Common Stock Acquisiton 2024-02-02 37 $5.71 6,475 No 4 P Indirect By Garry Paul Mauro SEP IRA
Common Stock Acquisiton 2024-01-10 5,000 $0.00 32,542 No 4 G Indirect By The Francesco A. Mauro Trust of 2021
Common Stock Acquisiton 2024-01-10 5,000 $0.00 32,542 No 4 G Indirect By The Andrew H. Mauro Trust of 2021
Common Stock Acquisiton 2024-01-10 5,000 $0.00 32,542 No 4 G Indirect By The Dominic C. Mauro Trust of 2021
Common Stock Acquisiton 2024-01-10 5,000 $0.00 32,542 No 4 G Indirect By The David W.B. Mauro Trust of 2021
Common Stock Acquisiton 2024-01-10 5,000 $0.00 32,542 No 4 G Indirect By The Alexandra P. Mauro Trust of 2021
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 G Direct
No 4 P Direct
No 4 G Indirect By Garry Paul Mauro SEP IRA
No 4 P Indirect By Garry Paul Mauro SEP IRA
No 4 G Indirect By The Francesco A. Mauro Trust of 2021
No 4 G Indirect By The Andrew H. Mauro Trust of 2021
No 4 G Indirect By The Dominic C. Mauro Trust of 2021
No 4 G Indirect By The David W.B. Mauro Trust of 2021
No 4 G Indirect By The Alexandra P. Mauro Trust of 2021
Footnotes
  1. Total number of shares has been adjusted to include the grant of 19,430 shares that were reported on Form 4 filed by the Reporting Person on November 15, 2022, but were inadvertently omitted from reports thereafter.